Background
==========

Primary osteoporosis, a skeletal disease characterized by imbalanced bone homeostasis, generally consists of postmenopausal osteoporosis and senile osteoporosis \[[@b1-medscimonit-21-1333]\]. Primary osteoporosis can occur in different age stages, but mainly in elderly people and postmenopausal women \[[@b2-medscimonit-21-1333],[@b3-medscimonit-21-1333]\]. In the US, over 50% of people who are age of 50 and above suffer from osteoporosis and nearly 80% of them are female \[[@b4-medscimonit-21-1333]\].

There are several reasons for the occurrence of primary osteoporosis. Mainly, it is caused by micro-architectural deterioration of bone tissues, which lead to decreased skeletal strength and increased susceptibility to fractures. Thus, there are higher risks of fragile fractures of vertebrae, femoral neck, and other typical localizations of lower incidence \[[@b1-medscimonit-21-1333],[@b5-medscimonit-21-1333]\].

The imbalance between bone resorption and formation is the main mechanism of osteoporosis. Normally, osteoclast cells resorb bone in bone marrow and deposit new bone by osteoblast \[[@b6-medscimonit-21-1333]\]. Recently, it has been found that the mutation of osteoclast genes such as CSF1(colony stimulating factor 1) \[[@b7-medscimonit-21-1333]\], PTH1R (parathyroid hormone 1 receptor), and osteoporosis related genes such as, LRP5 (low-density lipoprotein receptor-related protein 5) \[[@b8-medscimonit-21-1333]\], WNT3A (Wingless-type MMTV integration site family, member 3A) \[[@b9-medscimonit-21-1333]\], RANKL (Receptor Activator for Nuclear Factor-κ B Ligand), COL1A1 (Collagen, type I, alpha 1) \[[@b10-medscimonit-21-1333]\], and RUNX2 (Runt-related transcription factor 2) \[[@b11-medscimonit-21-1333]\] are relevant to osteoporosis. For example, CSF1 plays an important role in the development of bone, and it is vital for osteoclast proliferation, osteoclast differentiation, and bone resorption \[[@b12-medscimonit-21-1333]\]. PTH1R signaling is associated with the bone growth of cartilaginous growth plate postpartum \[[@b13-medscimonit-21-1333]\], and treatment with parathyroid hormone (PTH) is an approach for osteoporosis. However, the balance is hard to control. With the continuous activation of PTH1R, it could activate over-expression of RANKL, which would stimulates osteoclast formation and bone resorption \[[@b14-medscimonit-21-1333]\]. LRP5 mutations can reduce the activity of Wnt signaling and therefore lead to a decrease in bone formation \[[@b8-medscimonit-21-1333]\]. WNT3A is critically associated with bone mineral density (BMD) \[[@b9-medscimonit-21-1333]\] and COL1A1 is related to BMD reduction and increased fracture risk \[[@b10-medscimonit-21-1333]\].Therefore, in response to this skeletal disease, it is significant to analyze the related genes and transcription factors (TFs) that cause this disease. However, most of the current reports were focusing on related genes individually with unilateral analysis, which leads to a lack of understanding of the comprehensive interactions between regulating genes and proteins. Even by some modern methods such as meta-analysis, the relevant information could not be obtained easily because of many essential issues associated with annotation and comparison of cross-platforms.

In this paper, we analyzed the gene expressing profiles to investigate the differentially expressed genes (DEGs) of normal and the osteoporosis samples. TFs would be predicted with network tools. Then protein-protein interaction networks of these TFs were constructed using HPRD (the Human Protein Reference Database) and DIP (the Database of Interacting Proteins) databases. In addition, DAVID (The Database for Annotation, Visualization and Integrated Discovery) was applied to perform the GO (Gene Ontology) and KEGG (Kyoto Encyclopedia of Genes and Genomes) pathway enrichment analysis of DEGs and the corresponding TFs. Understanding the interactions between DEGs of TFs might provide references for the further exploration of the pathogenic mechanism of osteoporosis.

Material and Methods
====================

Under agreement of the ethics committee of the University of Würzburg, bone marrow was used with written informed consent of each patient \[[@b14-medscimonit-21-1333]\]. Non-osteoporotic donors were people who had total hip arthroplasty because of osteoarthritis and/or hip dysplasia. There were no nicotine abuse, alcohol abuse, usage of medications for these people.

Affymetrix microarray analysis
------------------------------

The gene expression profile dataset of GSE35958 \[[@b14-medscimonit-21-1333]\] was obtained from GEO (*<http://www.ncbi.nlm.nih.gov/geo/>*) database which is based on the Affymetrix Human Genome U133 Plus 2.0 Array platform. A total of 9 chips were available, including 5 human mesenchymal stem cell (MSC) samples from primary osteoporosis patients (79--94 years old, 5 females) and 4 age-matched human MSC of non-osteoporotic donors' control samples (donor age 79--89 years, 3 females and 1 male).The bone marrow of 4 control donors was collected from bone marrow of femoral heads using the described protocol \[[@b15-medscimonit-21-1333]\]. The 5 MSC samples of primary osteoporosis were isolated from femoral heads after low-energy fracture of the femoral neck. Further proof for primary osteoporosis of these 5 patients were their old-age and vertebrae fractures. The MSC cells were cultured and used for microarray as Benisch described \[[@b14-medscimonit-21-1333]\]. There were significant differences between MSC cells of osteoporosis and the controls according to Benisch \[[@b14-medscimonit-21-1333]\].

Data processing and DEGs screening
----------------------------------

Firstly, the original data in CEL format were processed into expression values by the robust multi-array average (RMA) method through the Affy package \[[@b16-medscimonit-21-1333]\] in R. Secondly, the probe-level data were transformed by R/Bioconductor platform notes package. Afterwards, background correction and quartile data normalization were performed.

The DEGs of mesenchymal stem cell between primary osteoporosis and normal bone tissues were identified by samr package \[[@b17-medscimonit-21-1333]\] in R software. The threshold value should be set as delta=1, minimum fold change=2. False discovery rate (FDR) less than 0.25 was chosen as cut-off criterion. Cluster analysis was applied to construct a dendrogram and to estimate the genetic distances of DEGs.

Function and pathway enrichment analysis of DEGs
------------------------------------------------

The Database for Annotation, Visualization, and Integrated Discovery (DAVID) \[[@b18-medscimonit-21-1333]\] was used to enrich GO functions and KEGG pathways of both up-regulated and down-regulated genes. FDR less than 0.05 were chosen as cut-off criteria.

TFs screening
-------------

Essaghir A method \[[@b19-medscimonit-21-1333]\] in Network tools (*[www.tfacts.com](www.tfacts.com)*) was used to predict the TFs of these DEGs and the interaction proteins were obtained based on data from the Human Protein Reference Database (HPRD: *<http://www.hprd.org>*) and Database of Interacting Proteins (DIP: *<http://dip.doe-mbi.ucla.edu>*) \[[@b19-medscimonit-21-1333],[@b20-medscimonit-21-1333]\]. TFs were screened with values of 4 indexes in TfactS (p-value, q-value, E-value, and FDR) less than 0.05. The up- and down-regulated DEGs were firstly uploaded to TfactS containing approved target genes of TFs. Then the DEGs were matched with positive or negative regulated target genes of TFs to identify the numbers of DEGs whose expressions were in the same (or opposite) direction with their regulations. Afterwards, activation or suppression of the TFs were identified through estimating the enrichment of genes with the same (or opposite) expressing direction to the regulating direction using the Fisher test.

Functional enrichment analysis of TFs
-------------------------------------

GO functions and KEGG pathways of both up- and down-regulated genes regulated by the predicted TFs were analyzed with DAVID \[[@b18-medscimonit-21-1333]\]. FDRs less than 0.05 were chosen as cut-off criteria.

Protein-Protein Interaction (PPI) network construction and analysis
-------------------------------------------------------------------

The protein interaction relationships corresponding to the DEGs regulated by predicted TFs were obtained using the STRING \[[@b20-medscimonit-21-1333]\] online database. PPI pairs with selected larger scores were used to construct the PPI network. Afterwards, the regulatory relationship between genes were analyzed and discussed through topological property of computing network such as the degree distribution of network, the shortest pathway distribution, average clustering coefficient, and closeness centrality.

Based on the above datasets, the regulatory network was constructed with transcriptome and their 88 regulator genes, including target genes, interacted with target genes and the upstream enzyme genes.

Results
=======

Data processing
---------------

A total of 21 049 genes in 9 samples were obtained after the preprocessing of expression profile. The original expression datasets from all conditions were processed into expression estimates using the RMA (Robust Multi-array Average) method. As shown in a box plot ([Figure 1](#f1-medscimonit-21-1333){ref-type="fig"}), the median of different samples was almost on the same line after normalization, which shows an excellent degree of standardization.

Identification of DEGs
----------------------

After cluster analysis of the expression value, a mesenchymal stem cell sample from primary osteoporosis in the same cluster with mesenchymal stem cell sample from normal bone tissues was excluded. A total of 579 DEGs of mesenchymal stem cells were screened in 4 normal bone tissues and 4 primary osteoporosis samples. As shown in [Figure 2](#f2-medscimonit-21-1333){ref-type="fig"}, there were 310 (53.54%) up-regulated genes in primary osteoporosis samples and 269 (46.46%). down-regulated genes The 10 most significant up- and down- regulated genes are listed in [Table 1](#t1-medscimonit-21-1333){ref-type="table"}. A total of 20 DEGs of minimum P values were screened using principal components analysis (PCA) for distinguishing control groups and disease groups. [Figure 3](#f3-medscimonit-21-1333){ref-type="fig"} shows PCA of the 20 most obvious DEGs.

Enrichment analysis of DEGs
---------------------------

There were 156 up-regulated genes obviously enriched in 56 GO terms and other seldom up-regulated genes mapped on hsa04510 (focal adhesion) pathways ([Figure 4](#f4-medscimonit-21-1333){ref-type="fig"}). As shown in [Table 2](#t2-medscimonit-21-1333){ref-type="table"}, it can be concluded that the 56 biological progresses in GO terms were mainly related to cell cycle, physical preparation of mitosis, and DNA replication. There were 35 down-regulated genes enriched in 3 GO terms, including nuclear lumen (GO: 0031981), intracellular organelle lumen (GO: 0070013), and nucleoplasm (GO: 0005654).

TFs screening
-------------

A total of 7 active TFs were obtained, including CTNNB1 (catenin (cadherin-associated protein), beta 1), E2F4 (E2F transcription factor 4), EGR1 (early growth response gene 1), JUN (jun proto-oncogene), SP1 (trans-acting transcription factor 1), TCF7L2 (Transcription factor 7-like 2), and TP53 (tumor protein p53). Then 88 interacting genes without the non-differential expressing genes were detected by analyzing the 7 TFs in DPRD and DIP. The numbers of target genes corresponding to these 7 TFs were 36, 9, 13, 31, 33, 6, and 40.

Enrichment analysis of TFs
--------------------------

GO enrichment analysis of the interacting DEGs and TFs indicated that 84 genes were obviously enriched in 310 biological processes, 57 genes were obviously enriched in 14 cellular component pathways, and 57 genes were obviously enriched in molecular function pathways. The top 10 GO terms of DEGs related to TFs are shown in [Table 3](#t3-medscimonit-21-1333){ref-type="table"}. It is obvious that more up-regulated genes were enriched in transcription regulator activity (GO: 0030528) and secondly in transcription factor activity (GO: 0003700).

Through KEGG pathways enrichment analysis, total 10 significant pathways of DEGs related to TFs were enriched ([Table 4](#t4-medscimonit-21-1333){ref-type="table"}). It included 5 cancer pathways and 3 signal pathways, such as colorectal cancer (has05210), Wnt signaling pathway (hsa04310), focal adhesion (hsa04510), and MAPK signaling pathway (hsa04010). Many of these genes were related to the cell cycle, cell apoptosis, cell junction, and focal adhesional pathways.

PPI network construction
------------------------

A total of 170 pairs of PPI with reliability index \>0.4 were selected for the construction of a PPI network using the String database ([Figure 5](#f5-medscimonit-21-1333){ref-type="fig"}). A total of 71 nodes were collected, which took 80.68% of all DEGs related to TFs. Generally, the protein interaction network of DEGs was in a state of high aggregation ([Figure 5](#f5-medscimonit-21-1333){ref-type="fig"}), which is an essential property of biological networks. In addition, it can be seen from [Figures 5](#f5-medscimonit-21-1333){ref-type="fig"} and [6](#f6-medscimonit-21-1333){ref-type="fig"} that most DEGs that have strong interaction relationships were significantly up-regulated. Furthermore, DEGs related to regulation of TFs were mostly up-regulated.

Further calculation on the topological parameters of network is shown in [Figure 7](#f7-medscimonit-21-1333){ref-type="fig"}. It can be seen in part A that the network node is in a power-law distribution form. From part B (shortest path length distribution), part C (average clustering coefficient), and part D (closeness centrality) it can be confirmed that this PPI network was characterized by small-world structure.

PPI network analysis
--------------------

The regulated network of TFs and related DEGs (binding protein) are shown in [Figure 7](#f7-medscimonit-21-1333){ref-type="fig"}. This network consisted of 7 TFs and 88 DEGs. Among the 7 TFs, CTNNB1, SP1, and TP53 regulated most up-regulated DEGs, which may play a crucial role in primary osteoporosis.

Discussion
==========

Although primary osteoporosis is rarely lethal, this disease contributes to millions of fractures every year \[[@b21-medscimonit-21-1333]\]. Previous research has mentioned many genes involved in pathogenesis of primary osteoporosis based on gene expression profiling. Mutations in CSF1 \[[@b7-medscimonit-21-1333]\] and LRP5 \[[@b8-medscimonit-21-1333]\] have been proven to be relevant to osteoporosis because of their ability to reduce the activity of Wnt signaling and therefore lead to a decrease in bone formation \[[@b8-medscimonit-21-1333]\]. Genes WNT3A \[[@b9-medscimonit-21-1333]\] and COL1A1 are related to BMD reduction \[[@b10-medscimonit-21-1333]\]. The interested DEGs are mostly the same in different reports, but many factors such as samples, platforms, and analysis methods would lead to the different results of chips. Most of these reports only concentrated on individual genes and lacked overall data. In response to this, many experts have made great efforts to obtain results from chips by meta-analysis, but many essential issues such as annotation and comparison of cross-platforms could not be solved appropriately. Additionally, there is an urgent need to understand the molecular mechanism of primary osteoporosis to develop better detection, diagnosis, and therapeutic targets that could improve clinical management and therapeutic outcome for patients.

Therefore, 2 datasets in a same platform were selected to analyze. Firstly, DEGs were screened by R language; we found that the DEGs and TFs were obviously enriched in certain GO terms and KEGG pathways related to cancer. Through GO term analysis, we found that up-regulated genes were only enriched in biological process and most of these biological processes were related to cell cycle, such as negative regulation of apoptosis, negative regulation of programmed cell death, and regulation of growth. GO terms associated with TFs mostly took part in biological process like cell cycle, cell apoptosis, and focal adhesion.

In KEGG enrichment analysis, 5 cancer pathways and 3 signaling pathways were enriched, including WNT signaling pathway and MAPK signaling pathway. The WNT signaling pathway plays an important role in cell proliferation, differentiation, morphogenesis, and oncogenesis \[[@b22-medscimonit-21-1333],[@b23-medscimonit-21-1333]\]. In 2001, Gong et al. reported that the WNT-β-catenin signaling pathway plays a vital role in regulating bone density through LRP5. Osteoblasts differentiation could be depressed by inhibiting β-catenin (Aliases for CTNNB1) expression \[[@b28-medscimonit-21-1333]\]. As the main regulator of bone formation \[[@b24-medscimonit-21-1333]\], the WNT signaling pathway has been confirmed to depress osteoclastogenesis and promote differentiation, proliferation, and mineralization of osteoblasts \[[@b25-medscimonit-21-1333]\]. The MAPK pathway was reported to be essential for formation of bones \[[@b26-medscimonit-21-1333]\]. In addition, over-proliferated cells are mitigated by depressing cyclin A transcriptional regulation and the cell cycle in primary osteoblasts \[[@b27-medscimonit-21-1333]\].

From this study, PPI network of DEGs was found to be in a state of high aggregation, which is an essential property of a biological network. In addition, it can be seen from [Figure 5](#f5-medscimonit-21-1333){ref-type="fig"} that most genes that have strong interaction relationships were up-regulated but there are few interactions among down-regulated genes. Moreover, most genes that related to TFs were up-regulated. *VEGF* (vascular endothelial growth factor) is up-regulated in osteoblastic precursor cells and is involved in bone formation by interaction with other TFs and genes \[[@b28-medscimonit-21-1333]\]. *TGFB1* (transforming growth factor beta-1) has positive correlations with peak bone mass \[[@b29-medscimonit-21-1333]\]. Among the 7 TFs predicted in this paper, JUN and TP53 took part in both WNT signaling pathway and MAPK pathway. TP53 was crucial for the development of many cancers, and it has an influence on many biology process like cell cycling, DNA repair, and apoptosis \[[@b30-medscimonit-21-1333]\]. Almost 90% of osteosarcomas are associated with TP53 mutation \[[@b31-medscimonit-21-1333]\]. JUN was found to be associated with human malignancies \[[@b32-medscimonit-21-1333]\]. CTNNB1 was a key down-regulated component of the canonical Wnt signaling pathway and takes part in the regulation of cell adhesion \[[@b33-medscimonit-21-1333]\]. E2F4 was found to be involved in cell cycle regulation and the over-expression of E2F4, which is related to many human cancers \[[@b34-medscimonit-21-1333]\]. SP1 participates in many cellular processes such as apoptosis and response to DNA damage. Through inducing TERT and TERC expression, SP1 can maintain telomerase activity in cancer with the help of TF7IP \[[@b35-medscimonit-21-1333]\]. Obviously, the samples we chose were based on the many enriched genes and TFs involved in cancer pathways. Most people who suffer from osteoporosis are elderly people, especially females \[[@b4-medscimonit-21-1333]\], and older people have more potential for cancer disease. Therefore, more research is needed for further analysis of the functions of TFs.

According to Benisch, DEGs of osteoporotic bones were significantly different from an age-matched control group. Comparing the osteoporotic bones with the healthy bones (middle-aged), there were also distinct gene products \[[@b14-medscimonit-21-1333]\]. This may indicate that osteoporosis can change gene expression pattern independent of age.

In conclusion, a total of 7 TFs -- CTNNB1, E2F4, EGR1, JUN, SP1, TCF7L2, and TP53 -- were enriched from gene-expressed database. CTNNB1, JUN, and TP53 are key elements in the WNT signaling pathway. CTNNB1 affected osteoblast differentiation. JUN, E2F4, SP1, and TP53 were found to be related to several cancers. For example, the mutations of TP53 may lead to osteosarcomas in humans \[36\]. The complex network constructed by TFs and genes is important in primary osteoporosis.

Conclusions
===========

Although many enriched genes that which seem to be highly associated with osteoporosis lack of research verification, this study supplies significant information for realizing the change of primary osteoporosis genes and the functions of TFs.

**Source of support:** Departmental sources

![Data distribution box plots. The horizontal axis represents the name of samples, while the vertical axis represents the expression value. The black lines stand for median, which can be used to identify the degree of standardization. The hMSC.old stood for the advanced age controls and the hMSC.OP stood for the 5 elderly patients of primary osteoporosis.](medscimonit-21-1333-g001){#f1-medscimonit-21-1333}

![Hierarchical clustering dendrogram of gene expression. Heat map of microarray results of primary osteoporosis and old controls. Total 579 DEGs were screened in 4 normal bone tissues mesenchymal stem cells and 4 primary osteoporosis mesenchymal stem cells. Through a process of gradual change color from red to green indicated expression values change from high to low.](medscimonit-21-1333-g002){#f2-medscimonit-21-1333}

![PCA of 20 most obvious DEGs. The horizontal axis represents the scores of first principal components and the vertical axis represents the scores of second principal components of samples. In the first principal components, 77.6% of variances from of 20 samples was explained while in the second principal component, 21.058% of variances from 20 samples was explained. Totally, the resolution degree of variances was 98.658%. In this figure, the hMSCold represented normal tissues (total of 4) while others were OP pateints.](medscimonit-21-1333-g003){#f3-medscimonit-21-1333}

![Focal adhesion KEGG pathways. Red color represents up-regulated genes and green color represents down-regulated genes.](medscimonit-21-1333-g004){#f4-medscimonit-21-1333}

![The PPI networks of DEGs. Red color represents up-regulated genes and green color represents down-regulated genes, connecting ling represent the relationships.](medscimonit-21-1333-g005){#f5-medscimonit-21-1333}

![Interaction networks of TFs and DEGs. The yellow ones represent TFs, the green ones represent down-regulated genes, the red ones represent up-regulated genes. The imaginarylines represented the interactions between DEGs related to TFs, while the solid lines represented the interactions between TFs and their regulated genes.](medscimonit-21-1333-g006){#f6-medscimonit-21-1333}

![Network nodes distribution. (**A**) Degree distribution of the network node. (**B**) Shortest path length distribution. (**C**) Average clustering coefficient. (**D**) Closeness centrality.](medscimonit-21-1333-g007){#f7-medscimonit-21-1333}

###### 

Top10 significantly enriched up- and down-regulated DEGs.

  Gene ID                                                                  Fold change   q-value   Expression change
  ------------------------------------------------------------------------ ------------- --------- -------------------
  BTBD2                                                                    4.946220309   0         Up
  TRIM28                                                                   5.069375389   0         Up
  PLD3                                                                     5.402783045   0         Up
  ZYX                                                                      6.746219455   0         Up
  PCDHGA10 /// PCDHGA11 /// PCDHGA12 /// PCDHGA3 /// PCDHGA5 /// PCDHGA6   7.183521479   0         Up
  NUCB1                                                                    7.665633376   0         Up
  PKM2                                                                     8.279466164   0         Up
  TRAPPC1                                                                  8.627312712   0         Up
  HSPB6                                                                    9.327560095   0         Up
  EPHX1                                                                    9.966633309   0         Up
  PPP3R1                                                                   0.117005561   0         Down
  SLC39A4 /// SLC39A7                                                      0.207061143   0         Down
  FAM13B                                                                   0.24379784    0         Down
  BAX                                                                      0.246579625   0         Down
  PRPF39                                                                   0.279206803   0         Down
  CTSZ                                                                     0.284363066   0         Down
  ZNF37A                                                                   0.297867371   0         Down
  LOC100507226                                                             0.29890838    0         Down
  ZNF468                                                                   0.306227022   0         Down
  FNIP1 /// RAPGEF6                                                        0.316884226   0         Down

###### 

Top 10 GO terms and KEGG pathways enrichment results of up-regulated genes.

  Category   Term                                                        Count   P-Value
  ---------- ----------------------------------------------------------- ------- -------------
  BP         GO: 0043066\~negative regulation of apoptosis               20      0.003334278
  BP         GO: 0060548\~negative regulation of cell death              20      0.003384174
  BP         GO: 0022610\~biological adhesion                            30      0.003427309
  BP         GO: 0043069\~negative regulation of programmed cell death   20      0.003592446
  BP         GO: 0030198\~extracellular matrix organization              12      0.003697203
  BP         GO: 0010941\~regulation of cell death                       33      0.003939575
  BP         GO: 0051094\~positive regulation of developmental process   17      0.004354961
  BP         GO: 0007155\~cell adhesion                                  30      0.004667666
  BP         GO: 0040008\~regulation of growth                           19      0.004702444
  BP         GO: 0046907\~intracellular transport                        28      0.005028033
  KEGG       hsa04510: Focal adhesion                                    19      3.30E-05

###### 

Top 10 GO terms enrichment results of TFs.

  Category        Term                                             Count   P-Value    Fold enrichment
  --------------- ------------------------------------------------ ------- ---------- -----------------
  GOTERM_MF_FAT   GO: 0003700\~transcription factor activity       27      6.75E-10   4.039654
  GOTERM_MF_FAT   GO: 0030528\~transcription regulator activity    33      1.37E-09   3.18381
  GOTERM_MF_FAT   GO: 0008134\~transcription factor binding        18      4.87E-08   5.11847
  GOTERM_MF_FAT   GO: 0043565\~sequence-specific DNA binding       19      1.00E-07   4.566148
  GOTERM_MF_FAT   GO: 0046983\~protein dimerization activity       17      6.08E-07   4.575459
  GOTERM_MF_FAT   GO: 0003690\~double-stranded DNA binding         8       4.05E-06   12.03104
  GOTERM_MF_FAT   GO: 0043566\~structure-specific DNA binding      9       6.03E-06   9.054398
  GOTERM_MF_FAT   GO: 0016563\~transcription activator activity    13      1.96E-05   4.625349
  GOTERM_MF_FAT   GO: 0019899\~enzyme binding                      14      4.77E-05   3.904913
  GOTERM_MF_FAT   GO: 0042803\~protein homodimerization activity   11      8.45E-05   4.804313

###### 

Top 10 KEGG pathways enrichment results of TFs.

  Category   Term                                       Count   FDR
  ---------- ------------------------------------------ ------- ----------
  PATHWAY    hsa05210: Colorectal cancer                9       4.21E-04
  PATHWAY    hsa04510: Focal adhesion                   12      7.02E-04
  PATHWAY    hsa05213: Endometrial cancer               7       8.02E-04
  PATHWAY    hsa05200: Pathways in cancer               14      0.001687
  PATHWAY    hsa05212: Pancreatic cancer                7       0.003085
  PATHWAY    hsa04310: Wnt signaling pathway            9       0.004867
  PATHWAY    hsa04210: Apoptosis                        7       0.006217
  PATHWAY    hsa05215: Prostate cancer                  7       0.006149
  PATHWAY    hsa04520: Adherens junction                6       0.019332
  PATHWAY    hsa04722: Neurotrophin signaling pathway   7       0.027373
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